Published in Ann Surg Oncol on April 14, 2014
Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status. World J Gastroenterol (2015) 0.77
Three angels are dancing on the head of the esophageal cancer pin, but shouldn't we not topple one or two? Ann Surg Oncol (2014) 0.75
Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res (2009) 2.61
Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell (2013) 2.23
Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res (2005) 2.05
Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol (2013) 1.79
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology (2006) 1.77
Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol (2007) 1.62
Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg (2003) 1.57
SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum (2009) 1.52
Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer. Ann Surg Oncol (2011) 1.50
High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci (2006) 1.49
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med (2012) 1.47
Endosonographic detection of mediastinal lymph node metastasis in superficial carcinoma of the esophagus: assessment by type classification and histogram. J Gastroenterol (2004) 1.47
Delayed gastric emptying after pancreatoduodenectomy. J Surg Res (2011) 1.45
EGFR mutations and human papillomavirus in lung cancer. Lung Cancer (2012) 1.41
The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng (2007) 1.35
Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology (2008) 1.33
Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res (2003) 1.30
Early experience of immediate reconstruction using autologous free dermal fat graft after breast conservational surgery. J Plast Reconstr Aesthet Surg (2006) 1.28
A case of successful enteroscopic balloon dilation for late anastomotic stricture of choledochojejunostomy after living donor liver transplantation. Liver Transpl (2005) 1.27
Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg (2005) 1.26
Substantial changes in central nervous system neurotransmitters and neuromodulators accompany phase change in the locust. J Exp Biol (2004) 1.25
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther (2008) 1.23
SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One (2013) 1.23
Trans-Oral Video-Assisted Neck Surgery (TOVANS). A new transoral technique of endoscopic thyroidectomy with gasless premandible approach. Surg Endosc (2012) 1.22
Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 1.18
Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg (2008) 1.17
Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg (2006) 1.15
Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res (2008) 1.13
B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci (2011) 1.12
Hand-assisted laparoscopic splenectomy and devascularization of the upper stomach in the management of gastric varices. World J Surg (2006) 1.12
Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res (2002) 1.10
Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res (2009) 1.10
Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer. J Surg Oncol (2011) 1.09
M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas (2013) 1.09
Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res (2004) 1.09
Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes. Clin Cancer Res (2008) 1.09
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). BMC Cancer (2013) 1.08
Lymph node micrometastasis and lymphatic mapping determined by reverse transcriptase-polymerase chain reaction in pN0 gastric carcinoma. Surgery (2002) 1.06
Subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) prevents postoperative delayed gastric emptying. J Surg Oncol (2010) 1.06
Clinical and pathologic evaluation of implanted free dermal fat grafts after breast cancer surgery: a retrospective analysis. Surgery (2011) 1.06
Surgery for hepatocellular carcinoma located in the caudate lobe. World J Surg (2009) 1.06
Mesothelin expression correlates with prolonged patient survival in gastric cancer. J Surg Oncol (2011) 1.05
Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis. Stem Cells (2008) 1.05
Sentinel lymph node mapping with GI cancer. Cancer Metastasis Rev (2006) 1.05
Immediate reconstruction using thoracodorsal adipofascial flap after partial mastectomy. Breast (2009) 1.04
Prognostic impact of CD133 expression in gastric carcinoma. Anticancer Res (2010) 1.04
CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol (2009) 1.03
Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer (2014) 1.03
Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep (2007) 1.03
Immediate reconstruction using inframammary adipofascial flap of the anterior rectus sheath after partial mastectomy. Am J Surg (2007) 1.02
Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer. Int J Cancer (2009) 1.02
Sentinel node micrometastases have high proliferative potential in gastric cancer. J Surg Res (2007) 1.02
Prompt chemoenzymatic synthesis of diverse complex-type oligosaccharides and its application to the solid-phase synthesis of a glycopeptide with Asn-linked sialyl-undeca- and asialo-nonasaccharides. Chemistry (2004) 1.01
Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. World J Surg (2011) 1.01
Immediate breast reconstruction using autologous free dermal fat grafts provides better cosmetic results for patients with upper inner cancerous lesions. Surg Today (2011) 1.01
Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis. Medicine (Baltimore) (2015) 1.00